Treatment of wet and dry types of age-related macular degeneration

Authors

  • Alvin Kwok

DOI:

https://doi.org/10.12809/hkjo-v25n2-319

References

Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet 2018;392:1147-59. DOI: https://doi.org/10.1016/S0140-6736(18)31550-2

Kwok AKH, Lam WC, Fong AHC, et al. Recommendations of the treat-and-extend regimen for neovascular agerelated macular degeneration: 2020 updates. Hong Kong J Ophthalmol 2021;25:39-46. DOI: https://doi.org/10.12809/hkjo-v25n2-306

Wong HL, Kwok AKH. Emerging treatments for dry agerelated macular degeneration with geographic atrophy: a systematic review. Hong Kong J Ophthalmol 2021;25:47-56. DOI: https://doi.org/10.12809/hkjo-v25n2-315

Apellis Pharmaceuticals. Apellis announces top-line results from phase 3 DERBY and OAKS studies in geographic atrophy (GA) and plans to submit NDA to FDA in the first half of 2022. Available from: https://investors.apellis.com/newsreleases/news-release-details/apellis-announces-top-lineresults-phase-3-derby-and-oaks. Accessed 29 Dec 2021.

Downloads

Published

2021-12-30

How to Cite

1.
Kwok A. Treatment of wet and dry types of age-related macular degeneration. Hong Kong J Ophthalmol [Internet]. 2021 Dec. 30 [cited 2026 Jul. 14];25(2). Available from: https://hkjo.hk/index.php/hkjo/article/view/319

Issue

Vol. 25 No. 2 (2021)

Section

Editorial

License

Copyright (c) 2021 Hong Kong Journal of Ophthalmology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

The Journal has a fully Open Access policy and publishes all articles under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. For any use other than that permitted by this license, written permission must be obtained from the Journal.

Most read articles by the same author(s)